196 related articles for article (PubMed ID: 28807569)
1. IL-10-Engineered Human CD4
Locafaro G; Andolfi G; Russo F; Cesana L; Spinelli A; Camisa B; Ciceri F; Lombardo A; Bondanza A; Roncarolo MG; Gregori S
Mol Ther; 2017 Oct; 25(10):2254-2269. PubMed ID: 28807569
[TBL] [Abstract][Full Text] [Related]
2. Engineered T Regulatory Type 1 Cells for Clinical Application.
Gregori S; Roncarolo MG
Front Immunol; 2018; 9():233. PubMed ID: 29497421
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-10 Gene-Modified Dendritic Cell-Induced Type 1 Regulatory T Cells Induce Transplant-Tolerance and Impede Graft Versus Host Disease After Allogeneic Stem Cell Transplantation.
Wan J; Huang F; Hao S; Hu W; Liu C; Zhang W; Deng X; Chen L; Ma L; Tao R
Cell Physiol Biochem; 2017; 43(1):353-366. PubMed ID: 28869950
[TBL] [Abstract][Full Text] [Related]
4. Pre-clinical development and molecular characterization of an engineered type 1 regulatory T-cell product suitable for immunotherapy.
Liu JM; Chen P; Uyeda MJ; Cieniewicz B; Sayitoglu EC; Thomas BC; Sato Y; Bacchetta R; Cepika AM; Roncarolo MG
Cytotherapy; 2021 Nov; 23(11):1017-1028. PubMed ID: 34404616
[TBL] [Abstract][Full Text] [Related]
5. Human allo-reactive CD4+ T cells as strong mediators of anti-tumor immunity in NOD/scid mice engrafted with human acute lymphoblastic leukemia.
Stevanović S; Griffioen M; Nijmeijer BA; van Schie ML; Stumpf AN; Rutten CE; Willemze R; Falkenburg JH
Leukemia; 2012 Feb; 26(2):312-22. PubMed ID: 21860431
[TBL] [Abstract][Full Text] [Related]
6. Killing of myeloid APCs via HLA class I, CD2 and CD226 defines a novel mechanism of suppression by human Tr1 cells.
Magnani CF; Alberigo G; Bacchetta R; Serafini G; Andreani M; Roncarolo MG; Gregori S
Eur J Immunol; 2011 Jun; 41(6):1652-62. PubMed ID: 21469116
[TBL] [Abstract][Full Text] [Related]
7. The Yin and Yang of Type 1 Regulatory T Cells: From Discovery to Clinical Application.
Sayitoglu EC; Freeborn RA; Roncarolo MG
Front Immunol; 2021; 12():693105. PubMed ID: 34177953
[TBL] [Abstract][Full Text] [Related]
8. Alloantigen-specific type 1 regulatory T cells suppress through CTLA-4 and PD-1 pathways and persist long-term in patients.
Chen PP; Cepika AM; Agarwal-Hashmi R; Saini G; Uyeda MJ; Louis DM; Cieniewicz B; Narula M; Amaya Hernandez LC; Harre N; Xu L; Thomas BC; Ji X; Shiraz P; Tate KM; Margittai D; Bhatia N; Meyer E; Bertaina A; Davis MM; Bacchetta R; Roncarolo MG
Sci Transl Med; 2021 Oct; 13(617):eabf5264. PubMed ID: 34705520
[TBL] [Abstract][Full Text] [Related]
9. HLA class II restricted T-cell reactivity to a developmentally regulated antigen shared by leukemic cells and CD34+ early progenitor cells.
Mutis T; Schrama E; van Luxemburg-Heijs SA; Falkenburg JH; Melief CJ; Goulmy E
Blood; 1997 Aug; 90(3):1083-90. PubMed ID: 9242539
[TBL] [Abstract][Full Text] [Related]
10. Allorestricted cytotoxic T cells specific for human CD45 show potent antileukemic activity.
Amrolia PJ; Reid SD; Gao L; Schultheis B; Dotti G; Brenner MK; Melo JV; Goldman JM; Stauss HJ
Blood; 2003 Feb; 101(3):1007-14. PubMed ID: 12393606
[TBL] [Abstract][Full Text] [Related]
11. Modeling the interaction between donor-derived regulatory T cells and effector T cells early after allogeneic hematopoietic stem cell transplantation.
Nishiyama N; Ruoff P; Jimenez JC; Miwakeichi F; Nishiyama Y; Yata T
Biosystems; 2023 May; 227-228():104889. PubMed ID: 37019377
[TBL] [Abstract][Full Text] [Related]
12. Generation of CD4+ cytotoxic T-lymphocyte clones from a patient with severe graft-versus-host disease after allogeneic bone marrow transplantation: implications for graft-versus-leukemia reactivity.
Faber LM; van Luxemburg-Heijs SA; Veenhof WF; Willemze R; Falkenburg JH
Blood; 1995 Oct; 86(7):2821-8. PubMed ID: 7670118
[TBL] [Abstract][Full Text] [Related]
13. Responses of regulatory and effector T-cells to low-dose interleukin-2 differ depending on the immune environment after allogeneic stem cell transplantation.
Meguri Y; Asano T; Yoshioka T; Iwamoto M; Ikegawa S; Sugiura H; Kishi Y; Nakamura M; Sando Y; Kondo T; Sumii Y; Maeda Y; Matsuoka KI
Front Immunol; 2022; 13():891925. PubMed ID: 35983059
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-2 inhibits graft-versus-host disease-promoting activity of CD4+ cells while preserving CD4- and CD8-mediated graft-versus-leukemia effects.
Sykes M; Harty MW; Szot GL; Pearson DA
Blood; 1994 May; 83(9):2560-9. PubMed ID: 7909457
[TBL] [Abstract][Full Text] [Related]
15. Graft Engineering and Adoptive Immunotherapy: New Approaches to Promote Immune Tolerance After Hematopoietic Stem Cell Transplantation.
Bertaina A; Roncarolo MG
Front Immunol; 2019; 10():1342. PubMed ID: 31354695
[TBL] [Abstract][Full Text] [Related]
16. Donor T cells administered over HLA class II barriers mediate antitumor immunity without broad off-target toxicity in a NOD/scid mouse model of acute leukemia.
Stevanović S; Nijmeijer BA; van Schie ML; Salvatori DC; Maas S; Griffioen M; Falkenburg JH
Biol Blood Marrow Transplant; 2013 Jun; 19(6):867-75. PubMed ID: 23500532
[TBL] [Abstract][Full Text] [Related]
17. Role of regulatory T cells in acute myeloid leukemia patients undergoing relapse-preventive immunotherapy.
Sander FE; Nilsson M; Rydström A; Aurelius J; Riise RE; Movitz C; Bernson E; Kiffin R; Ståhlberg A; Brune M; Foà R; Hellstrand K; Thorén FB; Martner A
Cancer Immunol Immunother; 2017 Nov; 66(11):1473-1484. PubMed ID: 28721449
[TBL] [Abstract][Full Text] [Related]
18. Th2 and Tc2 cells in the regulation of GVHD, GVL, and graft rejection: considerations for the allogeneic transplantation therapy of leukemia and lymphoma.
Fowler DH; Gress RE
Leuk Lymphoma; 2000 Jul; 38(3-4):221-34. PubMed ID: 10830730
[TBL] [Abstract][Full Text] [Related]
19. Plasmodium falciparum-mediated induction of human CD25Foxp3 CD4 T cells is independent of direct TCR stimulation and requires IL-2, IL-10 and TGFbeta.
Scholzen A; Mittag D; Rogerson SJ; Cooke BM; Plebanski M
PLoS Pathog; 2009 Aug; 5(8):e1000543. PubMed ID: 19680449
[TBL] [Abstract][Full Text] [Related]
20. Pharmacologic blockade of JAK1/JAK2 reduces GvHD and preserves the graft-versus-leukemia effect.
Choi J; Cooper ML; Alahmari B; Ritchey J; Collins L; Holt M; DiPersio JF
PLoS One; 2014; 9(10):e109799. PubMed ID: 25289677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
